Researchers look at benefits of flu vaccines in the elderly

by Sarah Craig

New research at the University of Notre Dame looks more closely at the effects of the influenza vaccine on the elderly, who are considered the highest-risk group for influenza-related mortality.

Despite the fact that the elderly are more susceptible to falling ill, very little is known about how well the performs for those older than 65 years of age. The new study, which looks at the effects of the influenza vaccine in Canada, is the largest to date in terms of numbers of individuals studied and duration. Seniors "age 65 and older are among those at highest risk of serious outcomes following ," said lead author Benjamin Ridenhour, assistant professor of biological sciences and a member of the Eck Institute for Global Health at Notre Dame, in a manuscript being published this week. While annual flu vaccines are recommended for the older population in the United States, Canada and many other developed countries, debate remains on the effectiveness of the vaccines for this older at-risk group.

The study, published in PLOS ONE, titled, "Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥65 years: Estimates with generalized linear models accounting for healthy vaccinee effects," questions the effectiveness of influenza vaccines in older adults. The researchers' findings indicate that previous estimates of influenza may be upwardly biased because of difficulties identifying and adjusting for confounders of the vaccine-outcome association. The authors said, "We estimated vaccine effectiveness for prevention of serious influenza complications among older persons by using methods to account for underlying differences in risk for these complications."

In their central findings of the research, the authors said, "By combining health data with climate data and developing novel statistical analyses, we found that vaccination was 19 percent effective at preventing pneumonia- or influenza-related hospitalizations and 25 percent effective at preventing death occurring subsequent to a pneumonia- or influenza-related hospitalization."

The results indicate that, over a long time period, the influenza vaccine has performed worse than expected in elderly individuals, thus proving the need for improvements in influenza vaccine development.

Annually, influenza kills approximately 25,000 people in the United States, according to the Centers for Disease Control and Prevention. Likewise, the World Health Organization estimates that nearly 500,000 deaths per year occur globally due to .

Ridenhour specializes in the evolution and ecology of infectious diseases. His research focuses on understanding their spatial and temporal dynamics with particular interest in understanding disease transmission to reduce global burden.

add to favorites email to friend print save as pdf

Related Stories

CDC: 2012-2013 flu vaccine not as effective in elderly

Feb 25, 2013

(HealthDay)—Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according ...

New moms and obese people risk complications from influenza

Aug 27, 2013

Although up to 500,000 people world-wide die of severe influenza each year, there has been no clear evidence about who is susceptible for influenza complications and it may not be who people think, says a study from McMaster ...

Recommended for you

Researchers discover target for treating dengue fever

40 minutes ago

Two recent papers by a University of Colorado School of Medicine researcher and colleagues may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other ...

Tracking flu levels with Wikipedia

56 minutes ago

Can monitoring Wikipedia hits show how many people have the flu? Researchers at Boston Children's Hospital, USA, have developed a method of estimating levels of influenza-like illness in the American population by analysing ...

User comments